流感病毒神经氨酸酶：结构、抗体与抑制剂
Influenza virus neuraminidase: structure, antibodies, and inhibitors.
作者信息
Colman P M
机构信息
Biomolecular Research Institute, Parkville, Victoria, Australia.
出版信息
Protein Sci. 1994 Oct;3(10):1687-96. doi: 10.1002/pro.5560031007.
Abstract
The determination of the 3-dimensional structure of the influenza virus neuraminidase in 1983 has served as a platform for understanding interactions between antibodies and protein antigens, for investigating antigenic variation in influenza viruses, and for devising new inhibitors of the enzyme. That work is reviewed here, together with more recent developments that have resulted in one of the inhibitors entering clinical trials as an anti-influenza virus drug.
摘要
1983年流感病毒神经氨酸酶三维结构的确定，为理解抗体与蛋白质抗原之间的相互作用、研究流感病毒的抗原变异以及设计该酶的新型抑制剂提供了一个平台。本文回顾了该项工作，以及最近的进展，这些进展已使其中一种抑制剂作为抗流感病毒药物进入临床试验阶段。
相似文献
1
Influenza virus neuraminidase: structure, antibodies, and inhibitors.流感病毒神经氨酸酶：结构、抗体与抑制剂
Protein Sci. 1994 Oct;3(10):1687-96. doi: 10.1002/pro.5560031007.
2
Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.4-胍基-唾液酸烯丙酯与流感病毒神经氨酸酶复合物的三维结构
Protein Sci. 1995 Jun;4(6):1081-7. doi: 10.1002/pro.5560040606.
3
The neuraminidase of influenza virus.流感病毒的神经氨酸酶
Proteins. 1989;6(4):341-56. doi: 10.1002/prot.340060402.
4
Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.通过分子对接、FMO计算和3D-QSAR CoMFA建模相结合的方法对人流感病毒神经氨酸酶（N1亚型）活性位点及其抑制剂进行结合相互作用分析。
J Chem Inf Model. 2008 Sep;48(9):1802-12. doi: 10.1021/ci800041k. Epub 2008 Aug 16.
5
Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.基于晶体神经氨酸酶结构修饰奥司他韦的类似物抑制剂用于治疗耐药H5N1病毒。
Biochem Biophys Res Commun. 2007 Oct 19;362(2):525-31. doi: 10.1016/j.bbrc.2007.08.025. Epub 2007 Aug 13.
6
Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.新型取代酰基（硫代）脲和噻二唑并[2,3-a]嘧啶衍生物作为流感病毒神经氨酸酶强效抑制剂的合成与评价
Bioorg Med Chem. 2006 Dec 15;14(24):8574-81. doi: 10.1016/j.bmc.2006.08.034. Epub 2006 Sep 18.
7
Anti-viral inhibitor binding to influenza neuraminidase by MALDI mass spectrometry.基质辅助激光解吸电离质谱法研究抗病毒抑制剂与流感神经氨酸酶的结合。
Anal Chem. 2012 Apr 17;84(8):3725-30. doi: 10.1021/ac300291c. Epub 2012 Mar 28.
8
Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.与扎那米韦相关的二氢吡喃羧酰胺：一类新型流感病毒唾液酸酶抑制剂。2. 甲型和乙型流感病毒4-氨基-4H-吡喃-6-羧酰胺与唾液酸酶复合物的晶体学和分子模拟研究
J Med Chem. 1998 Mar 12;41(6):798-807. doi: 10.1021/jm9703754.
9
Structure of a calcium-deficient form of influenza virus neuraminidase: implications for substrate binding.流感病毒神经氨酸酶钙缺乏形式的结构：对底物结合的影响
Acta Crystallogr D Biol Crystallogr. 2006 Sep;62(Pt 9):947-52. doi: 10.1107/S0907444906020063. Epub 2006 Aug 19.
10
Docking and 3D-QSAR investigations of pyrrolidine derivatives as potent neuraminidase inhibitors.作为强效神经氨酸酶抑制剂的吡咯烷衍生物的对接和 3D-QSAR 研究。
Chem Biol Drug Des. 2012 May;79(5):863-8. doi: 10.1111/j.1747-0285.2012.01330.x. Epub 2012 Feb 15.
引用本文的文献
1
Discovery of Novel Natural Inhibitors of H5N1 Neuraminidase Using Integrated Molecular Modeling and ADMET Prediction.利用综合分子建模和ADMET预测发现H5N1神经氨酸酶的新型天然抑制剂
Bioengineering (Basel). 2025 Jun 7;12(6):622. doi: 10.3390/bioengineering12060622.
2
Impact of Oseltamivir and Diabetes Development.奥司他韦与糖尿病发病的关联
Pharmaceuticals (Basel). 2025 Jan 18;18(1):128. doi: 10.3390/ph18010128.
3
Molecular characterization of the neuraminidase gene of virus in Northern Iran.伊朗北部病毒神经氨酸酶基因的分子特征分析
Virusdisease. 2023 Mar;34(1):21-28. doi: 10.1007/s13337-022-00806-7. Epub 2023 Feb 14.
4
Antiviral Approaches against Influenza Virus.抗流感病毒的策略。
Clin Microbiol Rev. 2023 Mar 23;36(1):e0004022. doi: 10.1128/cmr.00040-22. Epub 2023 Jan 16.
5
Structural and inhibitor sensitivity analysis of influenza B-like viral neuraminidases derived from Asiatic toad and spiny eel.亚洲蟾蜍和棘鳗来源的乙型流感样病毒神经氨酸酶的结构和抑制剂敏感性分析。
Proc Natl Acad Sci U S A. 2022 Oct 18;119(42):e2210724119. doi: 10.1073/pnas.2210724119. Epub 2022 Oct 3.
6
The arrival of highly pathogenic avian influenza viruses H5N8 in Iran through two windows, 2016.高致病性禽流感病毒 H5N8 于 2016 年通过两个窗口传入伊朗。
Virus Genes. 2022 Dec;58(6):527-539. doi: 10.1007/s11262-022-01930-8. Epub 2022 Sep 13.
7
Palladium catalysed carbonylation of 2-iodoglycals for the synthesis of C-2 carboxylic acids and aldehydes taking formic acid as a carbonyl source.钯催化2-碘糖的羰基化反应，以甲酸作为羰基源合成C-2羧酸和醛。
RSC Adv. 2019 Jul 17;9(39):22227-22231. doi: 10.1039/c9ra03626a.
8
The Antibody Response Against Neuraminidase in Human Influenza A (H3N2) Virus Infections During 2018/2019 Flu Season: Focusing on the Epitopes of 329--Glycosylation and E344 in N2.2018/2019流感季节人类甲型（H3N2）流感病毒感染中针对神经氨酸酶的抗体反应：聚焦于N2中329位糖基化和E344的表位
Front Microbiol. 2022 Mar 21;13:845088. doi: 10.3389/fmicb.2022.845088. eCollection 2022.
9
Structure-based design of stabilized recombinant influenza neuraminidase tetramers.基于结构的稳定重组流感神经氨酸酶四聚体设计。
Nat Commun. 2022 Apr 5;13(1):1825. doi: 10.1038/s41467-022-29416-z.
10
Influenza A virus diffusion through mucus gel networks.甲型流感病毒在黏液凝胶网络中的扩散。
Commun Biol. 2022 Mar 22;5(1):249. doi: 10.1038/s42003-022-03204-3.
本文引用的文献
1
Rational design of potent sialidase-based inhibitors of influenza virus replication.基于唾液酸酶的高效流感病毒复制抑制剂的合理设计。
Nature. 1993 Jun 3;363(6428):418-23. doi: 10.1038/363418a0.
2
Recombinant antineuraminidase single chain antibody: expression, characterization, and crystallization in complex with antigen.重组抗神经氨酸酶单链抗体：表达、表征及其与抗原复合物的结晶
Proteins. 1993 May;16(1):57-63. doi: 10.1002/prot.340160107.
3
Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase.副粘病毒血凝素神经氨酸酶与流感病毒神经氨酸酶的序列和结构比对。
J Virol. 1993 Jun;67(6):2972-80. doi: 10.1128/JVI.67.6.2972-2980.1993.
4
4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro.4-胍基-2,4-二脱氧-2,3-脱氢-N-乙酰神经氨酸是一种高效的唾液酸酶（神经氨酸酶）抑制剂，在体外对多种甲型和乙型流感病毒的生长也有抑制作用。
Antimicrob Agents Chemother. 1993 Jul;37(7):1473-9. doi: 10.1128/AAC.37.7.1473.
5
Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position.C-4位修饰的2-脱氧-2,3-二脱氢-N-乙酰神经氨酸类似物对病毒、细菌和哺乳动物来源的唾液酸酶的抑制作用
Glycoconj J. 1993 Feb;10(1):40-4. doi: 10.1007/BF00731185.
6
Affinity ranking of influenza neuraminidase mutants with monoclonal antibodies using an optical biosensor. Comparison with ELISA and slot blot assays.使用光学生物传感器对流感神经氨酸酶突变体与单克隆抗体进行亲和力排序。与酶联免疫吸附测定法和狭缝印迹法的比较。
J Immunol Methods. 1994 Jan 12;168(1):91-100. doi: 10.1016/0022-1759(94)90213-5.
7
Shape complementarity at protein/protein interfaces.蛋白质/蛋白质界面处的形状互补性。
J Mol Biol. 1993 Dec 20;234(4):946-50. doi: 10.1006/jmbi.1993.1648.
8
Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase.一种细菌唾液酸酶（来自鼠伤寒沙门氏菌LT2）的晶体结构显示出与流感病毒神经氨酸酶相同的折叠方式。
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9852-6. doi: 10.1073/pnas.90.21.9852.
9
Recombinant anti-sialidase single-chain variable fragment antibody. Characterization, formation of dimer and higher-molecular-mass multimers and the solution of the crystal structure of the single-chain variable fragment/sialidase complex.重组抗唾液酸酶单链可变片段抗体。特性、二聚体及高分子量多聚体的形成以及单链可变片段/唾液酸酶复合物晶体结构的解析
Eur J Biochem. 1994 Apr 1;221(1):151-7. doi: 10.1111/j.1432-1033.1994.tb18724.x.
10
Major antigen-induced domain rearrangements in an antibody.抗体中主要抗原诱导的结构域重排。
Structure. 1993 Oct 15;1(2):83-93. doi: 10.1016/0969-2126(93)90024-b.
Zotero 插件